Hearing on Approaches to Diagnostic Test Regulation and the Impact of the FDA’s Proposed Rule 2024-03-21 14:10

Hearing on Approaches to Diagnostic Test Regulation and the Impact of the FDA’s Proposed Rule 2024-03-21 14:10

E
Energy and Commerce Committee
Mar 22, 2024

The Subcommittee on Health of the Committee on Energy and Commerce will hold a hearing on Thursday, March 21, 2024, at 10 a.m. in the John D. Dingell Hearing Room, 2123 Rayburn House Office Building. The hearing is entitled, “Evaluating Approaches to Diagnostic Test Regulation and the Impact of the FDA’s Proposed Rule.”

Witnesses

Jeff Allen, PhD
President and CEO, Friends of Cancer Research

Dara L. Aisner, MD, PhD
Medical Director, Colorado Molecular Correlates Laboratory, Professor of Pathology, University of Colorado
Representative of the Academic Coalition for Effective Laboratory Developed Tests

Donald S. Karcher, MD, FCAP
President, College of American Pathologists (CAP)

Zach Rothstein, JD
Executive Director, AdvaMedDx

Susan Van Meter
President, American Clinical Laboratory Association (ACLA)

https://democrats-energycommerce.house.gov/committee-activity/hearings/hearing-evaluating-approaches-diagnostic-test-regulation-and-impact